CovertDS, FrankR.Atmospheric particles: behavior and functional effects. In: NadelJA, editor. Physiology and pharmacology of the airways. New York: Marcel Decker Inc; 1980:259.
2.
SkolnikNS. Treatment of croup: a critical review. Am J Dis Child1989;143(9):1045–1049.
3.
PerryLB. Topical anesthesia for bronchoscopy. Chest1978;73(5, Suppl):691–693.
4.
FryWA. Techniques of topical anesthesia for bronchoscopy. Chest1978;73(5, Suppl):694–696.
5.
McAlpineLG, ThomsonNC. Lidocaine-induced bronchoconstriction in asthmatic patients: relation to histamine airway responsiveness and effect of preservative. Chest1989;96(5):1012–1015.
6.
KirkpatrickMB. Lidocaine topical anesthesia for flexible bronchoscopy (editorial). Chest1989;96(5):965–967.
7.
BergerR, McConnellJW, PhillipsB, OvermanTL. Safety and efficacy of using high-dose topical and nebulized anesthesia to obtain endobronchial cultures. Chest1989;95(2):299–303.
8.
NaclerioRM. Allergic rhinitis. N Engl J Med1991;325(12):860–869.
9.
WitekTJ, SchachterEN. Pharmacology and therapeutics in respiratory care. Philadelphia: WB Saunders Co; 1994:49–50.
10.
PontiroliAE, CalderaraA, PozzaG.Intranasal drug delivery: potential advantages and limitations from a clinical pharmacokinetic perspective. Clin Pharmacokinet1989;17(5):299–307.
11.
SchoeffelRE, AndersonSD, AltounyanRE. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline. Br Med J Clin Res Ed1981;283(6302):1285–1287.
12.
EschenbacherWL, BousheyHA, SheppardD.Alteration in osmolarity of inhaled aerosols causes bronchoconstriction and cough, but absence of a permeant anion causes cough alone. Am Rev Respir Dis1984;129(2):211–215.
13.
SandersCVJr, LubyJP, JohansonWGJr, BarnettJA, SanfordJP. Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med1970;73(1):15–21.
14.
WilliamsOA, WilcoxMH, NicolCD, SpencerRC, ReillyCS. Lignocaine spray applicators are a potential source of cross-infection in the anaesthetic room. Anaesthesia1993;48(1):61–62.
OsguthorpeJD, ShirleyR.Neonatal respiratory distress from rhinitis medicamentosa. Laryngoscope1987;97(7, Part 1):829–831.
20.
BlueJA. Rhinitis medicamentosa. Ann Allergy1968;26(8):425–429.
21.
BlackMJ, RemsenKA. Rhinitis medicamentosa. Can Med Assoc J1980;8:122(4):881–884.
22.
Centers for Disease Control. Update: Universal Precautions for prevention and transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR1988;37(24):377–382, 387–388.
23.
Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related tissues. MMWR1990;39(RR-17):1–29.
24.
BradyMT. Nosocomial legionnaires' disease in a children's hospital. J Pediatr1989;115(1):46–50.
25.
MastroTD, FieldsBS, BreimanRF, CampbellJ, PlikaytisBD, SpikaJS. Nosocomial Legionnaires' disease and use of medication nebulizers. J Infect Dis1991;163(3):667–671.
